PATENT CLAIM ANALYSIS

Application Number: 16055396
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["514", "243000"]

Abstract:
The present invention relates to substituted pyrrole compounds which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity, in particular Jak family kinases. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such compounds or the pharmaceutical compositions containing them.

Claim (Index 42):
The method according to  claim 31  which provides tumor angiogenesis and metastasis inhibition.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.48889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15599025', '14418555', '15598976', '14235477', '14112559']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8662247480537145
- 35 USC 102 Novelty (BERT): 0.6038273952814462
- Combined Prediction Score: 0.8399850127764877
- Mean Citation Score: 546.5052059999998
- Max Citation Score: 636.0981
- Similarity Product: 446.1746649504125

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test